JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, B.
Right arrow Articles by Prasad, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, B.
Right arrow Articles by Prasad, K. N.
Journal of the American College of Nutrition, Vol. 21, No. 4, 339-343 (2002)
Published by the American College of Nutrition

D-Alpha-Tocopheryl Succinate (Vitamin E) Enhances Radiation-Induced Chromosomal Damage Levels in Human Cancer Cells, but Reduces it in Normal Cells

Bipin Kumar, MD, Mitra N. Jha, William C. Cole, PhD, Joel S. Bedford, DPhil and Kedar N. Prasad, PhD, FACN

Center for Vitamins and Cancer Research, Department of Radiology, University of Colorado Health Sciences Center, Denver (B.K., W.C., K.P.), Colorado
Department of Radiological Health Sciences, Colorado State University, Fort Collins (M.N.J., J.S.B.), Colorado

Address reprint requests to: Kedar N. Prasad, Ph.D., University of Colorado Health Sciences Center, 4200 East 9th Ave, Denver, CO 80262-0278. E mail: Kedar.Prasad{at}UCHSC.edu

Objective: The purpose of this study was to measure and compare the effect of d-{alpha}-tocopheryl succinate ({alpha}-TS) in modifying radiation-induced chromosomal damage in human normal cells and cancer cells in culture.

Methods: Three human normal fibroblast cell lines (GM2149, AG1522 and HF19) and three human cancer cell lines, cervical cancer (HeLa) and ovarian carcinoma cells (OVG1 and SKOV3) were treated with {alpha}-TS (37.6 µM) 20 hours before 100 cGy {gamma}-irradiation. After 30 minutes of irradiation, colcemid was added and cells were fixed. One hundred randomly selected metaphase cells were scored for the presence of chromatid gaps and breaks. To study the cellular accumulation of {alpha}-TS, cells were incubated in the presence of {alpha}-TS (18.8 and 37.6 µM) for 24 hours, and {alpha}-TS was extracted with hexane using {alpha}-tocopheryl acetate as an internal standard. The levels of {alpha}-TS were determined by HPLC.

Results: Results showed that {alpha}-TS induced chromosomal damage in both human cervical cancer cells and ovarian cancer cells, but not in human normal fibroblasts in culture. In addition, {alpha}-TS enhanced the level of radiation-induced chromosomal damage in cancer cells, but it protected normal cells against such damage. Both cancer cells and normal cells accumulated similar levels of {alpha}-TS, suggesting that increased sensitivity of cancer cells to {alpha}-TS is acquired during transformation.

Conclusion: The use of {alpha}-TS during radiation therapy may improve the efficacy of radiation therapy by enhancing tumor response and decreasing some of the toxicities on normal cells.

Key words: irradiation, radiation therapy, carcinoma, chromatid damage






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Nutrition.